anti-PD1 agent therapy - 2 years

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

anti-PD1 agent therapy - 2 years
Treatment and conditionWhere it standsTrials
anti-PD1 agent therapy - 2 years for endometrial neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1